XXA539B
Assistance Circulatory to New Technology Group 11 with Filtration, Ticagrelor, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | X Physiological Systems |
| Operation | A Assistance |
| Body Part | 5 Circulatory |
| Approach | 3 Percutaneous |
| Device | 9 Filtration, Ticagrelor |
| Qualifier | B New Technology Group 11 |
Operation Definition
Taking over a portion of a physiological function by extracorporeal means
Procedure Overview
Assistance procedures in this family involve a machine outside the body temporarily taking over part of a physiological function that the patient's own organs can no longer adequately perform. Unlike a full replacement, the device supplements or supports the function while leaving some of the underlying work to the body itself, and it operates extracorporeally, meaning blood or another substance is routed out of the body, processed, and returned.
These procedures are used in critical illness, most commonly when the heart, lungs, or another organ system is failing acutely and clinicians need a bridge to recovery, transplant, or another definitive treatment. Because the technology is classified under New Technology, it typically reflects a newer extracorporeal support device or circuit design that hasn't yet been absorbed into the standard PCS assistance tables.
Anatomy & Axis Detail
Circulatory
Assistance to the circulatory system using New Technology describes a device or technique that takes over or supports part of the heart or vascular system's own physiologic function, such as a novel mechanical circulatory support system that augments blood flow or pressure beyond what standard devices provide. This is applied in situations of severe cardiac or vascular compromise, where native circulatory performance is inadequate to sustain the patient without external support, and the emerging device is distinguished from established assist technologies by its novel mechanism or capability. Because circulatory assistance directly affects blood flow throughout the body, documentation must clearly describe how the device physically supports circulation and for what underlying condition. Coders should confirm the technology qualifies as New Technology rather than an already-established circulatory assist device captured elsewhere in the system.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Filtration, Ticagrelor
This qualifier identifies a specialized filter used in an extracorporeal circuit to selectively remove the antiplatelet drug ticagrelor from a patient's blood, typically before urgent cardiac surgery to reduce bleeding risk from residual drug activity. It differs from the pathogen-filtration device above, which targets microorganisms rather than a specific pharmaceutical agent.
Qualifier: New Technology Group 11
This qualifier designates Group 11, the most recent cohort at the time of its introduction, grouping technologies newly approved for New Technology section reporting in that fiscal year. Like every group value in this axis, it functions as an administrative marker rather than a description of the clinical intervention, which is captured elsewhere in the code. Its main point of confusion is with Group 10, the immediately preceding annual release.
Coding & Documentation
Coding from this family requires documentation that specifically identifies the extracorporeal device or system used and confirms that it is taking over, not fully replacing, the targeted function. The duration of support, the body system being assisted, and the specific product name are all typically needed to select the correct New Technology code value.
A frequent mistake is choosing between this code and a Performance code in the standard PCS tables, which applies when a machine completely takes over a function rather than assisting it - the two root operations sound similar but represent different degrees of organ takeover. Coders also sometimes fail to verify that the specific device documented is on the approved New Technology list for that code, defaulting instead to a generic extracorporeal support code.
Commonly Confused With
This family is most often mixed up with Performance, which fully takes over a function rather than assisting it, and with Extracorporeal Introduction procedures that deliver a substance rather than support a function directly. The key differentiator from Performance is the word "portion" in the definition - Assistance codes apply only when some native physiological activity remains, while full takeover belongs elsewhere.